Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Navio MD vs PrescribedRX

Navio MD and PrescribedRX both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Navio MD logo

Navio MD

8.2
★★★★☆4.1/5

Best for: moving between compounded and brand without changing seller

Visit Navio MD →
VS
PrescribedRX logo

PrescribedRX

6.0
★★★☆☆3/5

Best for: compounded semaglutide at $189/month

Visit PrescribedRX →

If you are choosing between Navio MD and PrescribedRX, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Navio MD leads our six-part score, 8.2 to 6.0.

Navio MD vs PrescribedRX price

Navio MD and PrescribedRX start at the same figure, $189 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide is cheaper at PrescribedRX ($189 a month vs $345 a month); tirzepatide is cheaper at Navio MD ($189 a month vs $276 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Navio MD prices compounded injections and brand-name pens, while PrescribedRX prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Navio MD is the only one of the two with a brand-name price.

Where each one treats patients

Navio MD lists 48 states, and PrescribedRX does not publish where it ships.

Pricing

Navio MD

Compound Tirzepatide (as low as, tiered by dose)Compounded
$189/mo
tirzepatide

as low as $189/mo; tiered by dose

Ozempic (as low as, tiered by dose)Brand-name
$345/mo
Ozempic

as low as $345/mo; brand price varies by dose

Zepbound (as low as, tiered by dose)Brand-name
$445/mo
Zepbound

as low as $445/mo; tiered by dose

Mounjaro (as low as, tiered by dose)Brand-name
$1249/mo
Mounjaro

as low as $1,249/mo; tiered by dose

StartingBrand-name
$345/mo
semaglutide

Ozempic as low as $345/mo (compounded tirzepatide $189/mo also offered)

PrescribedRX

Injectablecompounded injection
$189/mo
semaglutide

Monthly plan $189/mo; as low as $176/mo on the 3-month plan ($526)

Injectablecompounded injection
$276/mo
tirzepatide

Monthly plan $276/mo; as low as $233/mo on the 3-month plan ($697)

What each price covers

PrescribedRX's price also covers the clinician visit, the medication itself and shipping, which Navio MD does not claim.

Navio MD does not say what its price includes.

PrescribedRX is silent on lab work and coaching.

That matters most for the drug: unless Navio MD confirms otherwise, budget for medication on top of its listed price.

Navio MD

Inclusions not disclosed.

PrescribedRX

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Navio MD scores 8.2 and PrescribedRX 6.0 out of 10.

Navio MD is stronger on value (7.0 vs 4.8), user experience (8.0 vs 3.0), trust & safety (8.5 vs 4.0) and accessibility (9.7 vs 5.0).

PrescribedRX is stronger on support (7.0 vs 5.0).

Effectiveness is within half a point.

How we score

Navio MD

8.2/10

Overall

PrescribedRX

6.0/10

Value25%

7.0A
vs
B
4.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

8.5A
vs
B
4.0

Accessibility10%

9.7A
vs
B
5.0

Support10%

5.0A
vs
B
7.0

FDA warning letters

Neither Navio MD nor PrescribedRX has an FDA warning letter on record with us.

Features & Coverage

FeatureNavio MDPrescribedRX
Starting Price$189/mo$189/mo
Features6 features✓8 features
States Available48Not disclosed
Compounded✓ Yes—
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Navio MD

NavioMD sells compounded tirzepatide at $247/mo plus brand-name Ozempic at $1,199/mo and Mounjaro at $1,249/mo. It is LegitScript verified and available in 48 states, not AL or MS. The price is the same at every dose. It also offers women's hormone optimization.

Read our full Navio MD review →

About PrescribedRX

Sign with PrescribedRX for a 3-month plan and semaglutide falls from $189/month to $176, tirzepatide from $276/month to $233. Both are compounded GLP-1 injectables. The brand spans TRT, longevity, hair loss and sexual health besides weight, delivering monthly to the home under licensed US-provider oversight, and runs its site in English and Spanish with offers aimed at Florida and Palm Beach. It operates an affiliate program in-house. It identifies none of its compounding pharmacies and prints no state list.

Read our full PrescribedRX review →

Pros & Cons

Navio MD

What we like

  • Tirzepatide costs $189 a month, 24% below the $250 median for compounded tirzepatide across the sellers we compare
  • Semaglutide costs $345 a month, 65% below the $997 median for brand-name semaglutide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • Serves 48 states
  • We found no FDA warning letters issued to Navio MD

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its tirzepatide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

PrescribedRX

What we like

  • Semaglutide costs $189 a month, close to the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $276 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • The monthly price includes the medication, clinician visits and shipping
  • We found no FDA warning letters issued to PrescribedRX

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Navio MD

Navio MD wins this one, 8.2 to 6.0, above all for moving between compounded and brand without changing seller. PrescribedRX fits better if compounded semaglutide at $189/month is your priority.

Choose Navio MD if…

You want moving between compounded and brand without changing seller and an opening price near $189 a month.

Choose PrescribedRX if…

You want compounded semaglutide at $189/month and an opening price near $189 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.7

RxSpan MD

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

6.6

Luvo Health

Moving between compounded and brand without changing seller

8.4

Strut Health

Semaglutide at $99/month, 48% below the typical price

Navio MD vs PrescribedRX: FAQ

Neither on the entry price: Navio MD and PrescribedRX both start at about $189 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Navio MD lists 48 states; PrescribedRX does not publish where it ships. Confirm your state before paying.
Only PrescribedRX includes the clinician visit, the medication itself and shipping.
Navio MD has none. PrescribedRX has none.
No. Neither Navio MD nor PrescribedRX pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.